Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
- PMID: 37260439
- PMCID: PMC10229066
- DOI: 10.3389/fendo.2023.1158573
Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
Abstract
Background: Differentiating between adrenal Cushing syndrome (adrenal CS) and Cushing disease (CD) can be challenging if there are equivocal or falsely elevated adrenocorticotropic hormone (ACTH) values. We aim to investigate the diagnostic value of serum steroid profiles in differentiating adrenal CS from CD.
Method: A total of 11 serum steroids in adrenal CS (n = 13) and CD (n = 15) were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS). Age- and gender-specific steroid ratios were generated by dividing the actual steroid concentration by the upper limit of the relevant reference range. A principal component analysis (PCA) and an orthogonal partial least squares discriminant analysis (OPLS-DA) were performed.
Results: The PCA and OPLS-DA analyses showed distinct serum steroid profiles between adrenal CS and CD. Dehydroepiandrosterone sulfate (DHEA-S), dehydroepiandrosterone (DHEA), and androstenedione ratios were identified as biomarkers for discrimination by variable importance in projection (VIP) in combination with t-tests. The sensitivity and specificity of DHEA-S ratios <0.40 were 92.31% (95% CI 64.0%-99.8%) and 93.33% (95% CI 68.1%-99.8%), respectively, in identifying adrenal CS. The sensitivity and specificity of DHEA ratios <0.18 were 100% (95% CI 75.3%-100.0%) and 100% (95% CI 78.2%-100.0%), respectively, in identifying adrenal CS.
Conclusion: Our data support the clinical use of the DHEA-S and DHEA ratios in the differential diagnosis of adrenal CS and CD, especially when falsely elevated ACTH is suspected.
Keywords: Cushing syndrome; dehydroepiandrosterone sulfate (DHEA-S); mass spectrometry; orthogonal partial least squares discriminant analysis (OPLS-DA); serum steroids.
Copyright © 2023 Gao, Ding, Zhang, Yuan, Tang, Li, Ye, Liu and He.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Limited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation between Adrenal Cushing Syndrome and Cushing Disease.Endocrinol Metab (Seoul). 2015 Sep;30(3):297-304. doi: 10.3803/EnM.2015.30.3.297. Epub 2015 Aug 4. Endocrinol Metab (Seoul). 2015. PMID: 26248856 Free PMC article.
-
The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease.J Clin Endocrinol Metab. 2018 Feb 1;103(2):477-485. doi: 10.1210/jc.2017-01797. J Clin Endocrinol Metab. 2018. PMID: 29244084
-
Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation.J Clin Endocrinol Metab. 2013 Mar;98(3):1182-8. doi: 10.1210/jc.2012-2912. Epub 2013 Feb 5. J Clin Endocrinol Metab. 2013. PMID: 23386646 Free PMC article.
-
Androgens in Cushing's Syndrome.Front Horm Res. 2019;53:77-91. doi: 10.1159/000494904. Epub 2019 Sep 9. Front Horm Res. 2019. PMID: 31499501 Review.
-
Biochemical diagnosis of adrenal insufficiency: the added value of dehydroepiandrosterone sulfate measurements.Endocr Pract. 2011 Mar-Apr;17(2):261-70. doi: 10.4158/EP10262.RA. Endocr Pract. 2011. PMID: 21134877 Review.
Cited by
-
Clinical, hormonal and radiological features, and treatment outcomes of prolactinomas in a pediatric population.North Clin Istanb. 2024 Mar 29;12(3):269-276. doi: 10.14744/nci.2024.65049. eCollection 2025. North Clin Istanb. 2024. PMID: 40843322 Free PMC article.
-
No requirement of perioperative glucocorticoid replacement in patients with endogenous Cushing's syndrome - a pilot study.Endocrine. 2024 Aug;85(2):926-936. doi: 10.1007/s12020-024-03832-1. Epub 2024 Apr 22. Endocrine. 2024. PMID: 38647982 Free PMC article.
References
-
- Klose M, Kofoed-Enevoldsen A, Ostergaard Kristensen L. Single determination of plasma ACTH using an immunoradiometric assay with high detectability differentiates between ACTH-dependent and -independent cushing's syndrome. Scandinavian J Clin Lab Invest (2002) 62(1):33–7. doi: 10.1080/003655102753517181 - DOI - PubMed
-
- Hong AR, Kim JH, Hong ES, Kim IK, Park KS, Ahn CH, et al. . Limited diagnostic utility of plasma adrenocorticotropic hormone for differentiation between adrenal cushing syndrome and cushing disease. Endocrinol Metab (Seoul Korea) (2015) 30(3):297–304. doi: 10.3803/EnM.2015.30.3.297 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical